Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 5, 2009, Pages 664-675

  Ikeda, Hiroyuki ^a,b   Shiojima, Ichiro ^a,c   Ozasa, Yukako ^a   Yoshida, Masashi ^a   Holzenberger, Martin ^d   Kahn, C Ronald ^e   Walsh, Kenneth ^f   Igarashi, Takashi ^b   Abel, E Dale ^g   Komuro, Issei ^a,c  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HÔPITAL SAINT ANTOINE   (France)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac hypertrophy; Exercise; Insulin receptor; Insulin like growth factor receptor; Tyrosine phosphorylation

Indexed keywords

INSULIN; INSULIN RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXERCISE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; MUSCLE EXERCISE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRESS; SWIMMING;

ANIMALS; BLOTTING, WESTERN; CARDIOMEGALY; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; PHOSPHORYLATION; PHYSICAL CONDITIONING, ANIMAL; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; RECEPTORS, SOMATOMEDIN;

MUS;

EID: 70349734861     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.08.028     Document Type: Article

References (31)

1. Pasumarthi K.B., and Field L.J. Cardiomyocyte cell cycle regulation. Circ. Res. 90 (2002) 1044-1054
2. Olson E.N., and Schneider M.D. Sizing up the heart: development redux in disease. Genes Dev. 17 (2003) 1937-1956
3. Richey P.A., and Brown S.P. Pathological versus physiological left ventricular hypertrophy: a review. J. Sports Sci. 16 (1998) 129-141
4. Heineke J., and Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7 (2006) 589-600
5. Coats A.J. Exercise training for heart failure: coming of age. Circulation 99 (1999) 1138-1140
6. Konhilas J.P., Watson P.A., Maass A., Boucek D.M., Horn T., Stauffer B.L., Luckey S.W., Rosenberg P., and Leinwand L.A. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ. Res. 98 (2006) 540-548
7. McMullen J.R., Amirahmadi F., Woodcock E.A., Schinke-Braun M., Bouwman R.D., Hewitt K.A., Mollica J.P., Zhang L., Zhang Y., Shioi T., Buerger A., Izumo S., Jay P.Y., and Jennings G.L. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 612-617
8. Scheuer J., Malhotra A., Hirsch C., Capasso J., and Schaible T.F. Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. J. Clin. Invest. 70 (1982) 1300-1305
9. Shiojima I., and Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20 (2006) 3347-3365
10. Dorn Jr. G.W. The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49 (2007) 962-970
11. Neri Serneri G.G., Boddi M., Modesti P.A., Cecioni I., Coppo M., Padeletti L., Michelucci A., Colella A., and Galanti G. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89 (2001) 977-982
12. Scheinowitz M., Kessler-Icekson G., Freimann S., Zimmermann R., Schaper W., Golomb E., Savion N., and Eldar M. Short- and long-term swimming exercise training increases myocardial insulin-like growth factor-I gene expression. Growth Horm. IGF Res. 13 (2003) 19-25
13. Delaughter M.C., Taffet G.E., Fiorotto M.L., Entman M.L., and Schwartz R.J. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 13 (1999) 1923-1929
14. McMullen J.R., Shioi T., Huang W.Y., Zhang L., Tarnavski O., Bisping E., Schinke M., Kong S., Sherwood M.C., Brown J., Riggi L., Kang P.M., and Izumo S. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J. Biol. Chem. 279 (2004) 4782-4793
15. Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., Cantley L.C., and Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19 (2000) 2537-2548
16. McMullen J.R., Shioi T., Zhang L., Tarnavski O., Sherwood M.C., Kang P.M., and Izumo S. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12355-12360
17. Condorelli G., Drusco A., Stassi G., Bellacosa A., Roncarati R., Iaccarino G., Russo M.A., Gu Y., Dalton N., Chung C., Latronico M.V., Napoli C., Sadoshima J., Croce C.M., and Ross Jr. J. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12333-12338
18. Shiojima I., Sato K., Izumiya Y., Schiekofer S., Ito M., Liao R., Colucci W.S., and Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115 (2005) 2108-2118
19. DeBosch B., Treskov I., Lupu T.S., Weinheimer C., Kovacs A., Courtois M., and Muslin A.J. Akt1 is required for physiological cardiac growth. Circulation 113 (2006) 2097-2104
20. Kim J., Wende A.R., Sena S., Theobald H.A., Soto J., Sloan C., Wayment B.E., Litwin S.E., Holzenberger M., Leroith D., and Abel E.D. IGF-1 receptor signaling is required for exercise-induced cardiac hypertrophy. Mol. Endocrinol. 22 (2008) 2531-2543
21. Belke D.D., Betuing S., Tuttle M.J., Graveleau C., Young M.E., Pham M., Zhang D., Cooksey R.C., McClain D.A., Litwin S.E., Taegtmeyer H., Severson D., Kahn C.R., and Abel E.D. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest. 109 (2002) 629-639
22. Shiojima I., Yefremashvili M., Luo Z., Kureishi Y., Takahashi A., Tao J., Rosenzweig A., Kahn C.R., Abel E.D., and Walsh K. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J. Biol. Chem. 277 (2002) 37670-37677
23. Holzenberger M., Leneuve P., Hamard G., Ducos B., Perin L., Binoux M., and Le Bouc Y. A targeted partial invalidation of the insulin-like growth factor I receptor gene in mice causes a postnatal growth deficit. Endocrinology 141 (2000) 2557-2566
24. Abel E.D., Kaulbach H.C., Tian R., Hopkins J.C., Duffy J., Doetschman T., Minnemann T., Boers M.E., Hadro E., Oberste-Berghaus C., Quist W., Lowell B.B., Ingwall J.S., and Kahn B.B. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest. 104 (1999) 1703-1714
25. Leneuve P., Zaoui R., Monget P., Le Bouc Y., and Holzenberger M. Genotyping of Cre-lox mice and detection of tissue-specific recombination by multiplex PCR. Biotechniques 31 (2001) 1156-60,1162
26. Oka T., Maillet M., Watt A.J., Schwartz R.J., Aronow B.J., Duncan S.A., and Molkentin J.D. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 98 (2006) 837-845
27. Laustsen P.G., Russell S.J., Cui L., Entingh-Pearsall A., Holzenberger M., Liao R., and Kahn C.R. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol. Cell. Biol. 27 (2007) 1649-1664
28. Taniguchi C.M., Emanuelli B., and Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006) 85-96
29. Slaaby R., Schaffer L., Lautrup-Larsen I., Andersen A.S., Shaw A.C., Mathiasen I.S., and Brandt J. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J. Biol. Chem. 281 (2006) 25869-25874
30. Rother K.I., and Accili D. Role of insulin receptors and IGF receptors in growth and development. Pediatr. Nephrol. 14 (2000) 558-561
31. Denley A., Carroll J.M., Brierley G.V., Cosgrove L., Wallace J., Forbes B., and Roberts Jr. C.T. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol. Cell. Biol. 27 (2007) 3569-3577